Today's Low
₹ 2,034.00
Today's High
₹ 2,077.20
52 Weeks Low
₹ 583.00
52 Weeks High
₹ 788.90
Lower
₹ 1,864.25
Upper
₹ 2,278.45
Lupin Limited, a pharmaceutical company, develops, produces, markets, and sells a range of branded and generic formulations, biotechnology products, active pharmaceutical ingredients (APIs), and specialty products in India, the United States, Japan, and internationally. It offers formulations for use in the therapeutic areas of cardiovascular, diabetology, asthma, pediatrics, central nervous system, gastrointestinal, anti-infective, nonsteroidal anti-inflammatory drug therapy, respiratory, women's health, anti-tuberculosis, and cephalosporin, as well as digital therapeutics platform for doctors and patients. The company is also involved in the provision of biosimilar and over-the-counter products; and drug discovery and development programs in the therapeutic areas of oncology, immunology, and metabolic disorders, as well as bio clinical research activities. It has a licensing, development, and commercialization agreement with Boehringer Ingelheim for Lupin's MEK inhibitor compound (LNP3794) as a potential targeted therapy for patients with cancers. The company was formerly known as Lupin Chemicals Limited and changed its name to Lupin Limited in 2001 as a result of its amalgamation with Lupin Laboratories Limited. Lupin Limited was founded in 1968 and is headquartered in Mumbai, India.
No Data Found
No of shares Outstanding
EPS-TTM
Face Value
Book Value
Net Asset Value
ROE
ROA
ROCE
Dividend Yield
Total Debt
Sales Growth
PAT Growth
Particulars | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 | FY 2010 | FY 2009 | FY 2008 | FY 2007 | FY 2006 | FY 2005 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Current Assets | 12,451.3 | 12,457.7 | 13,986.4 | 15,413.2 | 13,853.6 | 12,209.5 | 11,952.9 | 9,887.4 | 7,832.4 | 6,100.5 | 5,143.1 | 4,342.3 | 3,504.2 | 2,775.5 | 2,230.9 | 2,044.1 | 1,462.9 | 1,331.5 | 718.9 |
Total Non-Current Assets | 10,349.0 | 9,193.8 | 9,443.9 | 9,396.3 | 13,361.8 | 13,379.3 | 14,146.7 | 12,401.6 | 5,221.2 | 4,034.8 | 3,700.3 | 3,593.1 | 2,869.3 | 2,290.5 | 1,764.1 | 1,305.6 | 799.9 | 674.6 | 635.3 |
Total Assets | 22,800.3 | 21,651.5 | 23,430.2 | 24,809.5 | 27,215.4 | 25,588.8 | 26,099.6 | 22,289.0 | 13,053.5 | 10,135.2 | 8,843.4 | 7,935.4 | 6,373.6 | 5,065.9 | 3,995.0 | 3,349.7 | 2,262.9 | 2,006.0 | 1,354.3 |
Total Current Liabilities | 9,265.4 | 8,276.4 | 8,436.1 | 9,225.2 | 6,129.9 | 5,095.6 | 6,120.6 | 5,061.2 | 3,729.2 | 2,629.6 | 3,006.9 | 3,120.3 | 2,507.4 | 1,189.3 | 1,216.2 | 747.0 | 422.2 | 362.4 | 313.0 |
Total Non-Current Liabilities | 992.1 | 1,153.1 | 1,136.0 | 3,003.2 | 7,296.4 | 6,876.1 | 6,447.0 | 6,032.4 | 426.2 | 507.2 | 572.9 | 730.0 | 533.6 | 1,283.4 | 1,339.7 | 1,313.6 | 967.4 | 1,018.8 | 550.7 |
Shareholder's Funds | 12,464.5 | 12,153.3 | 13,803.1 | 12,536.7 | 13,742.2 | 13,577.1 | 13,497.6 | 11,163.4 | 8,874.1 | 6,931.6 | 5,204.2 | 4,012.9 | 3,281.1 | 2,567.8 | 1,424.8 | 1,279.7 | 873.3 | 623.3 | 489.4 |
Total Liabilities | 22,800.3 | 21,651.5 | 23,430.2 | 24,809.5 | 27,215.4 | 25,588.8 | 26,099.6 | 22,289.0 | 13,053.5 | 10,135.2 | 8,843.4 | 7,935.4 | 6,373.6 | 5,065.9 | 3,995.0 | 3,349.7 | 2,262.9 | 2,006.0 | 1,354.3 |
The Industry Current Ratio stands at 2.30, vs the Current Ratio of 1.67, which results in a Negative aspect.
The Industry Debt to Equity Ratio stands at 0.23, vs the Debt to Equity Ratio of 0.51, which results in a Negative aspect.
The Industry Price to BV stands at 7.44, vs the Price to BV of 6.64, which results in a Negative aspect.
The Industry Quick Ratio stands at 1.60, vs the Quick Ratio of 1.30, which results in a Negative aspect.
Particulars | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 | FY 2010 | FY 2009 | FY 2008 | FY 2007 | FY 2006 | FY 2005 | FY 2004 | FY 2003 | FY 2002 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Income | 16,641.7 | 16,405.5 | 15,163.0 | 15,374.8 | 14,664.6 | 15,804.2 | 17,494.3 | 14,139.0 | 12,770.0 | 11,286.6 | 9,641.3 | 7,082.9 | 5,819.0 | 4,870.8 | 3,866.6 | 2,891.7 | 2,013.7 | 1,695.4 | 1,261.1 | 1,215.2 | 1,035.7 | 971.7 |
Total Expenditure | 14,921.1 | 16,190.2 | 12,596.1 | 13,020.0 | 12,103.8 | 12,656.6 | 13,001.2 | 10,453.7 | 9,150.4 | 8,283.8 | 7,371.4 | 5,638.2 | 4,641.1 | 3,886.9 | 3,127.4 | 2,270.5 | 1,721.5 | 1,471.8 | 1,127.7 | 993.3 | 851.0 | 793.4 |
Operating Profit(Excl OI) | 1,871.5 | 428.9 | 2,703.2 | 2,838.6 | 2,893.7 | 3,297.9 | 4,599.7 | 3,870.5 | 3,859.3 | 3,119.3 | 2,297.7 | 1,459.1 | 1,200.0 | 998.1 | 743.9 | 642.3 | 491.3 | 297.7 | 156.8 | 273.2 | 189.6 | 187.0 |
Add: Other Income | 150.9 | 213.7 | 136.3 | 483.8 | 333.0 | 150.4 | 106.5 | 185.2 | 239.8 | 116.5 | 27.9 | 14.4 | 22.2 | 14.2 | 4.6 | 21.1 | 199.1 | 74.1 | 23.4 | 51.4 | 4.9 | 8.8 |
Operating Profit | 1,871.5 | 428.9 | 2,703.2 | 2,838.6 | 2,893.7 | 3,297.9 | 4,599.7 | 3,870.5 | 3,859.3 | 3,119.3 | 2,297.7 | 1,459.1 | 1,200.0 | 998.1 | 743.9 | 642.3 | 491.3 | 297.7 | 156.8 | 273.2 | 189.6 | 187.0 |
Less: Interest | 274.3 | 142.8 | 140.6 | 363.0 | 302.5 | 204.4 | 152.5 | 59.5 | 9.8 | 26.7 | 41.0 | 35.5 | 34.5 | 38.5 | 49.9 | 37.4 | 37.2 | 31.3 | 28.3 | 52.6 | 64.6 | 64.4 |
PBDT | 1,597.2 | 286.1 | 2,562.5 | 2,475.6 | 2,591.2 | 3,093.5 | 4,447.1 | 3,811.1 | 3,849.5 | 3,092.6 | 2,256.8 | 1,423.6 | 1,165.6 | 959.6 | 694.0 | 605.0 | 454.1 | 266.4 | 128.6 | 220.6 | 124.9 | 122.6 |
Less: Depreciation Amortization | 880.7 | 1,658.7 | 887.4 | 970.2 | 846.1 | 1,085.9 | 912.2 | 487.1 | 434.7 | 261.0 | 332.2 | 227.5 | 171.2 | 123.9 | 88.0 | 64.7 | 46.6 | 40.9 | 33.6 | 29.5 | 25.6 | 23.8 |
PBT & Exceptional Items | 716.5 | -1,372.6 | 1,675.1 | 1,505.4 | 1,745.2 | 2,007.6 | 3,534.9 | 3,323.9 | 3,414.8 | 2,831.7 | 1,924.6 | 1,196.1 | 994.4 | 835.7 | 606.0 | 540.2 | 407.5 | 225.5 | 95.0 | 191.1 | 99.3 | 98.9 |
Less: Exceptional Income Expenses | 0.0 | 0.0 | 0.0 | -752.1 | -340.0 | -1,464.4 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -50.9 | 0.0 | 0.0 |
Profit Before Tax | 716.5 | -1,372.2 | 1,676.5 | 757.2 | 1,409.0 | 543.3 | 3,543.1 | 3,328.8 | 3,414.8 | 2,831.7 | 1,924.6 | 1,196.1 | 994.4 | 835.7 | 606.0 | 540.2 | 407.5 | 225.5 | 95.0 | 140.2 | 99.3 | 98.9 |
Less: Taxation | 268.8 | 137.2 | 448.5 | 1,157.1 | 887.9 | 288.5 | 978.5 | 1,059.3 | 970.4 | 962.2 | 584.2 | 308.6 | 115.0 | 136.0 | 98.3 | 131.8 | 98.8 | 52.1 | 2.7 | 51.8 | 24.1 | 24.2 |
Profit After Tax | 447.7 | -1,509.4 | 1,227.9 | -399.9 | 521.0 | 254.8 | 2,564.6 | 2,269.5 | 2,444.4 | 1,869.5 | 1,340.4 | 887.5 | 879.4 | 699.7 | 507.7 | 408.4 | 308.6 | 173.4 | 92.2 | 88.4 | 75.3 | 74.7 |
Earnings Per Share | 1.0 | -3.4 | 2.7 | -0.6 | 1.3 | 0.6 | 5.7 | 5.0 | 5.4 | 4.1 | 2.9 | 1.9 | 1.9 | 1.5 | 1.2 | 1.0 | 0.8 | 0.4 | 0.2 | 0.2 | 1.8 | 1.8 |
The Industry PE Ratio stands at 48.79, vs the PE Ratio of 43.97, which results in a Negative aspect.
The Industry Dividend Yield stands at 0.54, vs the Dividend Yield of 0.37, which results in a Negative aspect.
The Industry PAT Growth stands at 30.72, vs the PAT Growth of -176.75, which results in a Negative aspect.
The Industry PAT Margin stands at 9.78, vs the PAT Margin of -1.34, which results in a Negative aspect.
Particulars | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 | FY 2010 | FY 2009 | FY 2008 | FY 2007 | FY 2006 | FY 2005 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Profit Before Tax | 716.5 | -1,372.2 | 1,676.5 | 876.8 | 1,517.2 | 546.8 | 3,543.1 | 3,328.8 | 3,414.8 | 2,831.7 | 1,924.6 | 1,196.1 | 994.4 | 835.7 | 606.0 | 540.2 | 407.5 | 225.5 | 95.0 |
Tax Paid | -243.2 | 46.9 | -695.4 | -511.2 | -939.4 | -558.4 | -1,149.0 | -1,170.1 | -943.6 | -771.9 | -543.9 | -313.9 | -244.0 | -167.0 | -106.8 | -109.0 | -76.8 | -47.1 | -16.5 |
Adjustment | 1,097.4 | 1,707.7 | 1,033.2 | 1,574.3 | 1,588.4 | 2,782.2 | 1,214.7 | 585.4 | 356.7 | 410.5 | 419.6 | 258.5 | 207.2 | 144.3 | 144.2 | 86.2 | 49.4 | 71.5 | 62.2 |
Changes In Working Capital | 716.5 | -1,372.2 | 1,676.5 | 876.8 | 1,517.2 | 546.8 | 3,543.1 | 3,328.8 | 3,414.8 | 2,831.7 | 1,924.6 | 1,196.1 | 994.4 | 835.7 | 606.0 | 540.2 | 407.5 | 225.5 | 95.0 |
Cash Flow after changes in Working Capital | 2,140.4 | 320.4 | 2,517.1 | 1,980.1 | 2,605.4 | 2,309.6 | 5,262.5 | 787.8 | 3,676.7 | 2,775.8 | 1,794.8 | 873.9 | 1,042.0 | 843.4 | 576.4 | 367.5 | 254.7 | 178.7 | 137.8 |
Cash Flow from Operating Activities | 1,897.2 | 367.3 | 1,821.8 | 1,468.8 | 1,666.0 | 1,751.2 | 4,113.5 | -382.4 | 2,733.1 | 2,003.9 | 1,251.0 | 560.0 | 798.0 | 676.4 | 469.5 | 258.5 | 177.9 | 131.5 | 121.3 |
Cash Flow from Investing Activities | -1,286.8 | 1,292.2 | -1,239.6 | 1,107.0 | -3,282.5 | 469.9 | -2,527.4 | -6,961.7 | -1,054.5 | -858.5 | -521.9 | -741.3 | -519.6 | -680.2 | -509.6 | -491.8 | -151.6 | -77.2 | -128.2 |
Cash Flow from Financing Activities | -337.3 | -1,572.3 | -1,885.3 | -890.6 | 744.1 | -1,492.1 | 433.2 | 5,836.4 | -196.9 | -857.1 | -662.8 | 108.9 | -162.5 | 136.1 | -167.2 | 82.0 | -110.8 | 395.8 | 3.8 |
Net Cash Inflow / Outflow | 273.2 | 87.2 | -1,303.1 | 1,685.3 | -872.4 | 729.0 | 2,019.3 | -1,507.7 | 1,481.7 | 288.3 | 66.3 | -72.4 | 115.9 | 132.4 | -207.2 | -151.3 | -84.4 | 450.1 | -3.1 |
Opening Cash & Cash Equivalents | 991.4 | 926.2 | 2,229.3 | 544.1 | 1,416.4 | 687.5 | 780.2 | 2,095.1 | 606.6 | 310.9 | 244.7 | 295.9 | 164.2 | 68.1 | 270.7 | 385.7 | 477.2 | 27.1 | 30.2 |
Closing Cash & Cash Equivalent | 1,264.6 | 1,013.4 | 926.2 | 2,229.3 | 544.1 | 1,416.4 | 2,799.5 | 780.2 | 2,108.4 | 606.6 | 310.9 | 244.7 | 295.9 | 198.0 | 68.1 | 270.7 | 385.7 | 477.2 | 27.1 |
The Industry PFCF Ratio stands at 27.34, vs the PFCF Ratio of -69.48, which results in a Negative aspect.
The Industry PCF RATIO stands at 24.37, vs the PCF RATIO of 18.19, which results in a Negative aspect.
Particulars | Sep 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | Dec 2020 | Sep 2020 | Jun 2020 | Mar 2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 56,727.3 | 51,974.1 | 50,385.6 | 48,140.6 | 44,300.8 | 43,222.2 | 41,455.2 | 37,438.4 | 38,830.3 | 41,609.3 | 40,913.3 | 42,701.9 | 37,831.0 | 40,173.6 | 38,350.0 | 35,278.6 | 38,457.4 |
Total Income | 57,150.2 | 52,427.6 | 50,789.6 | 48,368.9 | 44,673.5 | 43,401.8 | 41,604.6 | 38,177.8 | 39,400.8 | 41,949.9 | 41,641.4 | 43,351.8 | 38,413.2 | 40,385.3 | 38,599.6 | 35,711.4 | 40,543.4 |
Total Expenditure | 43,323.7 | 41,754.5 | 41,208.0 | 39,577.7 | 38,523.1 | 37,895.5 | 36,925.3 | 35,799.0 | 36,565.8 | 37,911.0 | 54,151.8 | 33,426.2 | 30,755.5 | 32,386.2 | 32,538.3 | 30,397.8 | 33,204.2 |
PBIDT (Excl OI) | 13,403.6 | 10,219.6 | 9,177.6 | 8,562.9 | 5,777.7 | 5,326.7 | 4,529.9 | 1,639.4 | 2,264.5 | 3,698.3 | -13,238.5 | 9,275.7 | 7,075.5 | 7,787.4 | 5,811.7 | 4,880.8 | 5,253.2 |
Other Income | 422.9 | 453.5 | 404.0 | 228.3 | 372.7 | 179.6 | 149.4 | 739.4 | 570.5 | 340.6 | 728.1 | 649.9 | 582.2 | 211.7 | 249.6 | 432.8 | 2,086.0 |
Operating Profit | 13,826.5 | 10,673.1 | 9,581.6 | 8,791.2 | 6,150.4 | 5,506.3 | 4,679.3 | 2,378.8 | 2,835.0 | 4,038.9 | -12,510.4 | 9,925.6 | 7,657.7 | 7,999.1 | 6,061.3 | 5,313.6 | 7,339.2 |
Interest | 708.7 | 740.1 | 806.4 | 856.7 | 925.5 | 840.9 | 548.8 | 427.8 | 414.7 | 334.0 | 344.3 | 334.7 | 318.4 | 309.2 | 336.2 | 442.6 | 1,073.8 |
Exceptional Items | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 830.9 |
PBDT | 13,117.8 | 9,933.0 | 8,775.2 | 7,934.5 | 5,224.9 | 4,665.4 | 4,130.5 | 1,951.0 | 2,420.3 | 3,704.9 | -12,854.7 | 9,590.9 | 7,339.3 | 7,689.9 | 5,725.1 | 4,871.0 | 7,096.3 |
Depreciation | 2,569.2 | 2,572.0 | 2,478.5 | 2,346.6 | 2,639.9 | 2,204.0 | 2,034.7 | 1,928.3 | 3,271.9 | 2,034.3 | 9,193.3 | 2,087.6 | 2,157.2 | 2,443.2 | 2,127.3 | 2,146.4 | 2,142.6 |
Profit Before Tax | 10,548.6 | 7,361.0 | 6,296.7 | 5,587.9 | 2,585.0 | 2,461.4 | 2,095.8 | 22.7 | -851.6 | 1,670.6 | -22,048.0 | 7,503.3 | 5,182.1 | 5,246.7 | 3,597.8 | 2,724.6 | 4,953.7 |
Tax | 1,953.8 | 1,174.0 | 1,343.5 | 1,054.6 | 161.1 | 884.9 | 751.1 | 890.9 | 4,267.3 | -3,820.0 | -1,099.1 | 2,023.3 | 540.1 | 834.9 | 1,467.0 | 1,643.2 | 1,050.7 |
Provisions and contingencies | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Profit After Tax | 8,594.8 | 6,187.0 | 4,953.2 | 4,533.3 | 2,423.9 | 1,576.5 | 1,344.7 | -868.2 | -5,118.9 | 5,490.6 | -20,948.9 | 5,480.0 | 4,642.0 | 4,411.8 | 2,130.8 | 1,081.4 | 3,903.0 |
Net Profit | 8,594.8 | 6,187.0 | 4,953.2 | 4,533.3 | 2,423.9 | 1,576.5 | 1,344.7 | -868.2 | -5,118.9 | 5,490.6 | -20,948.9 | 5,480.0 | 4,642.0 | 4,411.8 | 2,130.8 | 1,081.4 | 3,903.0 |
ADDITIONAL INFOS: | |||||||||||||||||
Equity Capital | 912.3 | 910.7 | 910.5 | 910.2 | 910.0 | 909.6 | 909.4 | 909.3 | 909.0 | 908.4 | 908.1 | 907.8 | 907.4 | 907.0 | 906.5 | 906.2 | 906.0 |
Reserves | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
EPS | 18.7 | 13.5 | 10.8 | 9.9 | 5.2 | 3.4 | 2.9 | -2.0 | -11.4 | 12.0 | -46.2 | 12.0 | 10.2 | 9.7 | 4.7 | 2.4 | 8.6 |
Operating Profit Margin | 24.4 | 20.5 | 19.0 | 18.3 | 13.9 | 12.7 | 11.3 | 6.4 | 7.3 | 9.7 | -30.6 | 23.2 | 20.2 | 19.9 | 15.8 | 15.1 | 19.1 |
Net Profit Margin | 15.2 | 11.9 | 9.8 | 9.4 | 5.5 | 3.6 | 3.2 | -2.3 | -13.2 | 13.2 | -51.2 | 12.8 | 12.3 | 11.0 | 5.6 | 3.1 | 10.1 |
The Industry Mcap Growth stands at 19.96, vs the Mcap Growth of -20.12, which results in a Negative aspect.
The Industry Net Sales Growth stands at 11.06, vs the Net Sales Growth of 4.84, which results in a Negative aspect.
Type | Classic | Woodie | Camarilla |
---|---|---|---|
R4 | 2,157.75 | 2,193.08 | 2,095.11 |
R3 | 2,130.90 | 2,136.15 | 2,083.23 |
R2 | 2,104.05 | 2,106.68 | 2,079.27 |
R1 | 2,087.70 | 2,092.95 | 2,075.31 |
Pivot | 2,060.85 | 2,063.48 | 2,060.85 |
S1 | 2,044.50 | 2,049.75 | 2,067.39 |
S2 | 2,017.65 | 2,020.28 | 2,063.43 |
S3 | 2,001.30 | 2,006.55 | 2,059.47 |
S4 | 1,984.95 | 1,933.88 | 2,047.59 |
(All Values are in INR)
1 Day
1 Week
1 Month
Stoch RSI
100.00
Bearish
RSI
84.31
Bearish
ROC
-5.06
Bearish
UltimateOscillator
50.86
Neutral
Williams Indicator
-67.40
Neutral
CCI Indicator
-65.51
Neutral
MACD
-1,681.43
Bearish
Stochastic Indicator
28.28
Neutral
ATR
81.80
High Volatility
Ex-Date | Ratio | Record Date |
---|
Ex-Date | Ratio | Record Date |
---|---|---|
Announcement Date | Dividend Amount | Dividend Percentage of FV | Dividend Type |
---|---|---|---|
14-07-2023 | 4.00 | 200 | Final |
14-07-2022 | 4.00 | 200 | Final |
27-07-2021 | 6.50 | 325 | Final |
Date Of Conduct | Board Meeting Details |
---|---|
07-11-2024 | Quarterly Results |
07-02-2024 | Quarterly Results |
08-11-2023 | Quarterly Results |
03-08-2023 | Quarterly Results |
09-05-2023 | Audited Results & Final Dividend |
09-02-2023 | Quarterly Results |
09-11-2022 | Quarterly Results |
03-08-2022 | Quarterly Results |
18-05-2022 | Final Dividend & Audited Results |
03-02-2022 | Quarterly Results |
27-10-2021 | Quarterly Results |
10-08-2021 | Quarterly Results |
12-05-2021 | Final Dividend & Audited Results |